JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32578

Anti-EGFR (phospho Y1173) 抗体 [E124]

Anti-EGFR (phospho Y1173) antibody [E124]

Be the first to review this product! Submit a review

|

(38 Publications)

Rabbit Recombinant Monoclonal EGFR phospho Y1173 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 38 publications.

別名を表示する

ERBB, ERBB1, HER1, EGFR, Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1

4 Images
Flow Cytometry (Intracellular) - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)

Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) treated (Red)/untreated (Green) with 500ng/ml Trichostatin A for 4 hours with purified ab177178 at 1/1300 dilution. The secondary antibody was Goat anti rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution. A Rabbit monoclonal IgG (Black) was used as the isotype control and cells without incubation with primary antibody and secondary antibody (Blue) were used as unlabeled control.

Immunocytochemistry/ Immunofluorescence - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)

Immunocytochemistry analysis of A431 (Human epidermoid carcinoma epithelial cell) treated with EGF(100ng/ml 5min) cells labeling EGFR with Purified ab32578 at 1 : 2000 dilution (0.1 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Western blot - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)
  • WB

Unknown

Western blot - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)

All lanes:

Western blot - Anti-EGFR (phospho Y1173) antibody [E124] (ab32578) at 1/1000 dilution

Lane 1:

Untreated A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate

Lane 2:

A431 (Human epidermoid carcinoma epithelial cell) treated with 100ng/ml EGF for 30 minutes whole cell lysate

Lane 3:

A431 (Human epidermoid carcinoma epithelial cell) treated with 100ng/ml EGF for 30 minutes whole cell lysate, then the membrane treated with Alkaline Phosphatase for 1 hour

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 134 kDa

false

Western blot - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)
  • WB

CiteAb

Western blot - Anti-EGFR (phospho Y1173) antibody [E124] (AB32578)

EGFR (phospho Y1173) western blot using anti-EGFR (phospho Y1173) antibody [E124] ab32578. Publication image and figure legend from Bönisch, M., Sellmann, C., et al., 2017, Protein Eng Des Sel, PubMed 28981885.

ab32578 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab32578 please see the product overview.

Biophysical and functional characterisation of B10v5 × hu225M with or without mutations in the CH1 : CL interface. Analytical SEC after protein A purification of bsAbs produced in (A) HEK293-6E or (B) bsAbs produced in ExpiCHO after preparative SEC. The area under the curve in percent of all detected peak areas is given in the graph. (C) Simultaneous binding of both antigens cMET and EGFR using biolayer interferometry. BsAbs (wt, MaB40, MaB5/40, MaB21/40, MaB45/40) or antibodies consisting of only one Fab (oa for ‘one-armed’) were allowed to bind to cMET coated biosensors. Subsequently, biosensors were incubated with EGFR. (D) Differential scanning calorimetry of wildtype, interface mutants and ‘one-armed’ constructs (Table III). (E) Western blot analysis of the inhibition of EGFR and cMET phosphorylation in A549 cells by bsAbs with our without interface designs.

false

関連する標識済み抗体及び組成の異なる製品 (4)

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-EGFR (phospho Y1173) antibody [E124]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-EGFR (phospho Y1173) antibody [E124]

  • Carrier free

    Anti-EGFR (phospho Y1173) antibody [E124] - BSA and Azide free

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-EGFR (phospho Y1173) antibody [E124]

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

E124

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

ICC/IF, WB, Flow Cyt (Intra)

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

The antibody detects EGFR phosphorylated on Tyrosine 1173 of the mature human isoform 1 (corresponding to Y1197 from the precursor).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/25 - 1/50", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>" } } }

製品の詳細

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS, 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

EGFR or Epidermal Growth Factor Receptor is a transmembrane glycoprotein that acts as a receptor for members of the epidermal growth factor family. Known alternatively as ErbB1 or HER1 this receptor has an approximate molecular weight of 170 kDa. EGFR is expressed in various cell types notably on epithelial cells and can influence multiple cellular processes through its kinase activity. It participates in the regulation of cell growth multiplication and survival by activating its kinase domain upon ligand binding.
Biological function summary

The EGFR protein plays an important role in cellular communication and signaling processes. EGFR pairs with other receptor family members to form active dimers or even higher-order complexes which in turn initiate intracellular signaling cascades. Through these complexes EGFR influences many processes including cell differentiation and repair. This function of EGFR makes it an integral part of mammalian biology affecting how cells respond to their environment by mediating changes in gene expression.

Pathways

EGFR is a central player in the MAPK and PI3K/Akt signaling pathways. Alongside other protein partners like KRAS and PI3 kinase it contributes to transmitting signals from the cell surface to the nucleus affecting gene transcription and cell behavior. These pathways are important for normal cell growth and division and aberrations in these pathways can lead to excessive or insufficient cell proliferation.

EGFR is pertinent to cancer biology including non-small cell lung cancer and glioblastoma where mutations or overexpression of the receptor frequently occur. It connects to proteins such as PTEN and BRAF which influence tumor progression and response to targeted therapies. EGFR's involvement in these disorders highlights its significance as a therapeutic target since it can be manipulated to alter disease progression.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

The protein expressed by the EGFR gene functions as a receptor tyrosine kinase, binding with ligands from the EGF family to activate several signaling cascades that translate extracellular signals into cellular responses. Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen, BTC/betacellulin, epiregulin, and HBEGF. Ligand binding triggers receptor dimerization and autophosphorylation, recruiting adapter proteins like GRB2 and activating complex downstream signaling pathways such as RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC, and STATs, and possibly the NF-kappa-B cascade. EGFR also directly phosphorylates proteins like RGS16 and MUC1, influencing various cellular processes including its coupling with G protein-coupled receptor signaling and cell migration through interaction with CCDC88A/GIV. Isoform 2 of EGFR may act as an antagonist to EGF actions. In microbial infection, EGFR also serves as a receptor facilitating hepatitis C virus (HCV) entry into hepatocytes by promoting CD81-CLDN1 receptor complexes and enhancing membrane fusion with HCV envelope glycoproteins. This supplementary information is collated from multiple sources and compiled automatically.
See full target information EGFR phospho Y1173

文献 (38)

Recent publications for all applications. Explore the full list and refine your search

Journal of extracellular biology 3:e141 PubMed38939899

2024

RAB31 drives extracellular vesicle fusion and cancer-associated fibroblast formation leading to oxaliplatin resistance in colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Chan Chang,Yi-Fang Yang,Chien-Hsiu Li,Ming-Hsien Chan,Meng-Lun Lu,Ming-Huang Chen,Chi-Long Chen,Michael Hsiao

Molecular cancer therapeutics 22:667-678 PubMed36921315

2023

Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Tressie A Posey,Joan Jacob,Ashlyn Parkhurst,Shraddha Subramanian,Liezl E Francisco,Zhengdong Liang,Kendra S Carmon

Cancer cell 40:754-767.e6 PubMed35820397

2022

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.

Applications

Unspecified application

Species

Unspecified reactive species

Yasir Y Elamin,Jacqulyne P Robichaux,Brett W Carter,Mehmet Altan,Hai Tran,Don L Gibbons,Simon Heeke,Frank V Fossella,Vincent K Lam,Xiuning Le,Marcelo V Negrao,Monique B Nilsson,Anisha Patel,R S K Vijayan,Jason B Cross,Jianjun Zhang,Lauren A Byers,Charles Lu,Tina Cascone,Lei Feng,Rajyalakshmi Luthra,Francis A San Lucas,Geeta Mantha,Mark Routbort,George Blumenschein,Anne S Tsao,John V Heymach

Frontiers in cardiovascular medicine 9:797137 PubMed35224040

2022

ADAMTS8 Promotes Cardiac Fibrosis Partly Through Activating EGFR Dependent Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yafang Zha,Yanyan Li,Zhuowang Ge,Jian Wang,Yuheng Jiao,Jiayan Zhang,Song Zhang

Journal of cellular physiology 237:1780-1789 PubMed34806177

2021

Overexpression of N-acetylglucosaminyltransferase V promotes human parotid gland acinar cell immortalization via the epidermal receptor activation.

Applications

Unspecified application

Species

Unspecified reactive species

Ching-Chia Cheng,Chih-Feng Lin,Yong-Chong Lin,Tai-Horng Young,Pei-Jen Lou

Pathology international 71:752-764 PubMed34528330

2021

Expression of astrocyte-elevated gene-1 indicates prognostic value of fluoropyrimidine-based adjuvant chemotherapy in resectable stage III colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Long-Wei Lin,Peng-Sheng Lai,Ying-Yin Chen,Chung-Yu Chen

Experimental and therapeutic medicine 21:638 PubMed33968169

2021

Gallic acid suppresses colon cancer proliferation by inhibiting SRC and EGFR phosphorylation.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoming Lin,Guangfei Wang,Ping Liu,Lei Han,Tong Wang,Kaili Chen,Yonglin Gao

Carbohydrate polymers 261:117911 PubMed33766385

2021

Cell detachment ratio on pH-responsive chitosan: A useful biometric for prognostic judgment and drug efficacy assessment in oncology.

Applications

Unspecified application

Species

Unspecified reactive species

Chia-Hsiang Yen,Tai-Horng Young,Tsung-Wei Huang

Neoplasia (New York, N.Y.) 23:36-48 PubMed33217668

2020

Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3.

Applications

Unspecified application

Species

Unspecified reactive species

Zhihui Zhu,Jingtao Yuan,Xintong Xu,Yingying Wei,Bo Yang,Huajun Zhao

International journal of cancer 148:1438-1451 PubMed32949162

2020

Integrating proteomics into precision oncology.

Applications

Unspecified application

Species

Unspecified reactive species

Leonie W Wahjudi,Stephan Bernhardt,Khalid Abnaof,Peter Horak,Simon Kreutzfeldt,Christoph Heining,Simone Borgoni,Corinna Becki,Daniela Berg,Daniela Richter,Barbara Hutter,Sebastian Uhrig,Katrin Pfütze,Jonas Leichsenring,Hanno Glimm,Benedikt Brors,Christof von Kalle,Albrecht Stenzinger,Ulrike Korf,Stefan Fröhling,Stefan Wiemann
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com